|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Q, Shi J, Yuan F, Wang H, Fu W, Pan
J, Huang Y, Yu J, Yang J and Chen Z: Higher expression of XPF is a
critical factor in intrinsic chemotherapy resistance of human renal
cell carcinoma. Int J Cancer. 139:2827–2837. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dos Santos M, Brachet PE, Chevreau C and
Joly F: Impact of targeted therapies in metastatic renal cell
carcinoma on patient-reported outcomes: Methodology of clinical
trials and clinical benefit. Cancer Treat Rev. 53:53–60. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L, Yuan L, Qian K, Qian G, Zhu Y, Wu
CL, Dan HC, Xiao Y and Wang X: Identification of biomarkers
associated with pathological stage and prognosis of clear cell
renal cell carcinoma by co-expression network analysis. Front
Physiol. 9:3992018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goto-Yamaguchi L, Yamamoto-Ibusuki M,
Yamamoto Y, Fujiki Y, Tomiguchi M, Sueta A, Takeshita T and Iwase
H: Therapeutic predictors of neoadjuvant endocrine therapy response
in estrogen receptor-positive breast cancer with reference to
optimal gene expression profiling. Breast Cancer Res Treat.
172:353–362. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tse LA, Dai J, Chen M, Liu Y, Zhang H,
Wong TW, Leung CC, Kromhout H, Meijer E, Liu S, et al: Prediction
models and risk assessment for silicosis using a retrospective
cohort study among workers exposed to silica in China. Sci Rep.
5:110592015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gatto F, Blum KA, Hosseini SS, Ghanaat M,
Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, et
al: Plasma glycosaminoglycans as diagnostic and prognostic
biomarkers in surgically treated eenal cell carcinoma. Eur Urol
Oncol. 1:364–377. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang SC, Wang ST, Liu HT, Wang XY, Wu SC,
Chen LC and Liu YW: Trichostatin A induces bladder cancer cell
death via intrinsic apoptosis at the early phase and Sp1-survivin
downregulation at the late phase of treatment. Oncol Rep.
38:1587–1596. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sweis RF, Spranger S, Bao R, Paner GP,
Stadler WM, Steinberg G and Gajewski TF: Molecular drivers of the
non-T-cell-inflamed tumor microenvironment in urothelial bladder
cancer. Cancer Immunol Res. 4:563–568. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen F, Zhang Y, Bossé D, Lalani AA,
Hakimi AA, Hsieh JJ, Choueiri TK, Gibbons DL, Ittmann M and
Creighton CJ: Pan-urologic cancer genomic subtypes that transcend
tissue of origin. Nat Commun. 8:1992017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maniecki MB, Etzerodt A, Ulhøi BP,
Steiniche T, Borre M, Dyrskjøt L, Orntoft TF, Moestrup SK and
Møller HJ: Tumor-promoting macrophages induce the expression of the
macrophage-specific receptor CD163 in malignant cells. Int J
Cancer. 131:2320–2331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai S, McOlash L, Palen K, Johnson B,
Duris C, Yang Q, Dwinell MB, Hunt B, Evans DB, Gershan J, et al:
Development of primary human pancreatic cancer organoids, matched
stromal and immune cells and 3D tumor microenvironment models. BMC
Cancer. 18:3352018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia-Gomez A, Rodríguez-Ubreva J and
Ballestar E: Epigenetic interplay between immune, stromal and
cancer cells in the tumor microenvironment. Clin Immunol.
196:64–71. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia D, Li S, Li D, Xue H, Yang D and Liu
Y: Mining TCGA database for genes of prognostic value in
glioblastoma microenvironment. Aging (Albany NY). 10:592–605. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gan TQ, Chen WJ, Qin H, Huang SN, Yang LH,
Fang YY, Pan LJ, Li ZY and Chen G: Clinical value and prospective
pathway signaling of microRNA-375 in lung adenocarcinoma: A study
based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus
(GEO) and bioinformatics analysis. Med Sci Monit. 23:2453–2464.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
R Core Team, . 2012.R: A language and
environment for statistical computing. R Foundation for Statistical
Computing. (Vienna, Austria). Available online at
https://www.R-project.org/.
|
|
19
|
RStudio Team, . RStudio: Integrated
Development for R. RStudio, Inc.; Boston, MA: 2015, http://www.rstudio.com/
|
|
20
|
Haque M, Sarmah R and Bhattacharyya DK: A
common neighbor based technique to detect protein complexes in PPI
networks. J Genet Eng Biotechnol. 16:227–238. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47(D1): D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Patel H, Nilendu P, Jahagirdar D, Pal JK
and Sharma NK: Modulating secreted components of tumor
microenvironment: A masterstroke in tumor therapeutics. Cancer Biol
Ther. 19:3–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chevrier S, Levine JH, Zanotelli VRT,
Silina K, Schulz D, Bacac M, Ries CH, Ailles L, Jewett MAS, Moch H,
et al: An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell.
169:736–749.e18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Herting CJ, Chen Z, Pitter KL, Szulzewsky
F, Kaffes I, Kaluzova M, Park JC, Cimino PJ, Brennan C, Wang B, et
al: Genetic driver mutations define the expression signature and
microenvironmental composition of high-grade gliomas. Glia.
65:1914–1926. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng M, Brägelmann J, Schultze JL and
Perner S: Web-TCGA: An online platform for integrated analysis of
molecular cancer data sets. BMC Bioinformatics. 17:722016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Andreeva E, Bobyleva P, Gornostaeva A and
Buravkova L: Interaction of multipotent mesenchymal stromal and
immune cells: Bidirectional effects. Cytotherapy. 19:1152–1166.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schelker M, Feau S, Du J, Ranu N, Klipp E,
MacBeath G, Schoeberl B and Raue A: Estimation of immune cell
content in tumour tissue using single-cell RNA-seq data. Nat
Commun. 8:20322017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghatalia P, Gordetsky J, Kuo F, Dulaimi E,
Cai KQ, Devarajan K, Bae S, Naik G, Chan TA, Uzzo R, et al:
Prognostic impact of immune gene expression signature and tumor
infiltrating immune cells in localized clear cell renal cell
carcinoma. J Immunother Cancer. 7:1392019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai J, Lu Y, Roca H, Keller JM, Zhang J,
McCauley LK and Keller ET: Immune mediators in the tumor
microenvironment of prostate cancer. Chin J Cancer. 36:292017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kamal Y, Cheng C, Frost HR and Amos CI:
Predictors of disease aggressiveness influence outcome from
immunotherapy treatment in renal clear cell carcinoma.
OncoImmunology. 8:e15001062018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Faurobert E, Bouin AP and Albiges-Rizo C:
Microenvironment, tumor cell plasticity, and cancer. Curr Opin
Oncol. 27:64–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Wen W, Yuan J, Helfand B, Li Y,
Shi C, Tian F, Zheng J, Wang F, Chen L, et al: Immunotherapy for
human renal cell carcinoma by adoptive transfer of autologous
transforming growth factor beta-insensitive CD8+ T cells. Clin
Cancer Res. 16:164–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li M, Li M, Yin T, Shi H, Wen Y, Zhang B,
Chen M, Xu G, Ren K and Wei Y: Targeting of cancer-associated
fibroblasts enhances the efficacy of cancer chemotherapy by
regulating the tumor microenvironment. Mol Med Rep. 13:2476–2484.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raguraman R, Parameswaran S, Kanwar JR,
Khetan V, Rishi P, Kanwar RK and Krishnakumar S: Evidence of tumour
microenvironment and stromal cellular components in retinoblastoma.
Ocul Oncol Pathol. 5:85–93. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang J, Späth SS, Marjani SL, Zhang W and
Pan X: Characterization of cancer genomic heterogeneity by
next-generation sequencing advances precision medicine in cancer
treatment. Precis Clin Med. 1:29–48. 2018. View Article : Google Scholar : PubMed/NCBI
|
